QMDT Stock Overview
A life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Quick-Med Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -99.98% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| QMDT | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 1.0% |
| 1Y | n/a | 3.9% | 31.4% |
Return vs Industry: Insufficient data to determine how QMDT performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how QMDT performed against the US Market.
Price Volatility
| QMDT volatility | |
|---|---|
| QMDT Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: QMDT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine QMDT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | Bernd Liesenfeld | www.quickmedtech.com |
Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company’s core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications.
Quick-Med Technologies, Inc. Fundamentals Summary
| QMDT fundamental statistics | |
|---|---|
| Market cap | US$37.00 |
| Earnings (TTM) | -US$713.07k |
| Revenue (TTM) | US$928.49k |
0.0x
P/S Ratio0.0x
P/E RatioIs QMDT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QMDT income statement (TTM) | |
|---|---|
| Revenue | US$928.49k |
| Cost of Revenue | US$800.34k |
| Gross Profit | US$128.15k |
| Other Expenses | US$841.23k |
| Earnings | -US$713.07k |
Last Reported Earnings
Jun 30, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did QMDT perform over the long term?
See historical performance and comparison